MINNEAPOLIS, MINNESOTA – Lifecore Biomedical, Inc. recently held its Q3 2025 Earnings Conference Call, offering investors and analysts insights into the company’s performance. The call, which took place on April 3, 2025, at 4:30 PM ET, featured key executives from Lifecore, including CEO Paul Josephs and CFO Ryan Lake.

Stephanie Diaz, the Manager of Investor Relations at Lifecore, kicked off the conference call by welcoming participants and providing an overview of the agenda. The executives discussed the company’s third quarter fiscal 2025 earnings results and highlighted important aspects of its financial performance.

During the call, Paul Josephs, the President and CEO of Lifecore, emphasized the importance of transparency by addressing the forward-looking statements made during the discussion. He reminded participants that these statements are based on current information and may not necessarily reflect future outcomes accurately.

Ryan Lake, the CFO of Lifecore, also shared insights into the company’s financial standing and underscored the importance of reviewing the risks and uncertainties associated with forward-looking statements. He encouraged participants to refer to the company’s filings with the Securities and Exchange Commission for a comprehensive understanding of these factors.

Overall, the Q3 2025 Earnings Conference Call provided stakeholders with valuable updates on Lifecore Biomedical, Inc.’s performance and financial outlook. The executives’ presentations shed light on the company’s strategies and goals moving forward, positioning Lifecore for potential growth and success in the future.